• 深圳市朗司医疗科技有限公司(简称:朗司医疗,LemnisCare),是由国内外博士团队创立,一家专业从事“智慧生物安全城市”领域产品及服务,集研发、生产和销售的国家高新技术企业。公司人才梯队齐全,学科背景丰富,与多个高等院校、医疗机构、疾控中心等开展长期科研合作,致力于通过科技创新,构建“城市-社区-家庭”的生物安全技术体系,为实现智慧生物安全城市努力。

  • 深圳市朗司医疗科技有限公司(简称:朗司医疗,LemnisCare),是由国内外博士团队创立,一家专业从事“智慧生物安全城市”领域产品及服务,集研发、生产和销售的国家高新技术企业。公司人才梯队齐全,学科背景丰富,与多个高等院校、医疗机构、疾控中心等开展长期科研合作,致力于通过科技创新,构建“城市-社区-家庭”的生物安全技术体系,为实现智慧生物安全城市努力。

  • 喜报 |  朗司医疗顺利通过高新技术企业认定!

    有梦一起批才会赢--朗司医疗2020年终总结大会圆满落幕!

    喜报 | 朗司医疗获批一类医疗器械备案凭证

     

     

     

     

  • 微量分液系列
    核酸提取系列
  • 产品说明书
    产品目录
    产品视频
    产品彩页
  • 未来的你:

           有好多话要和你说,但现在长话短说。在你到来之前,等待属于漫长;我们在这里等你,希望你的才识与行动,为我们带来效益与进步,我们在这里等你,期待你的努力与幽默,为团队带来能量与喜悦,,我们在这里等你......期待你的每一刻,我们都在成长,成为优秀的自己。让年轻在成长的舞台不会孤单,来,我们在朗司医疗等你,加入我们!

  • 联系我们
    合作机构
    客户服务
  • 回到顶部
  • 0755-26406206
  • QQ客服
  • 微信二维码

Congratulations! LemnisCare Successfully Gain  the National High-Tech Enterprise Certification

 

Recently, Shenzhen LemnisCare Medical Technology Co., LTD. successfully passed the third batch of National High-Tech Enterprise Certification in 2020. It is reported that High-Tech Enterprises are special qualification certification set up by the state to support, encourage and commend the development of high-tech enterprises, adjust the industrial structure and enhance the national economic competitiveness, which occupies a high important strategic position in the economic development of our country. This certification has strict examine and verify requirements for the core intellectual property rights, R & D investment, R & D team building, scientific and technological achievements transformation ability, organization and management ability, growth ability and other comprehensive index owned by the enterprise.

 

The award of the National High-Tech Enterprise Certification is the recognition and affirmation of the government to LemnisCare. It is also an important embodiment of LemnisCare's outstanding achievements in independent innovation and basic medical construction. It is the result of the joint efforts of all employees and provides strong support for LemnisCare in the market competition!

 

Since its establishment in 2017, LemnisCare has been engaged in R&D, production, sales and service in the field of molecular diagnosis and has a number of core technology patents. The self-developed automated nucleic acid extractor, biological aerosol sampler, automated micro reagent dispenser and other products have been successfully applied in hospitals, disease control, universities, animal husbandry and other fields. By the end of 2020, LemnisCare has achieved more than 50,000 product sales and more than 2,000 service customers.

 

Commited to technology innovation, Lemniscare is making health services popular and reliable and all the human health and happiness. In the future, we will continue to expand R&D investment, establish a R&D technology team guided by the market, which can respond to market feedback and meet market demand quickly. We are supposed to give full play to the responsibility and mission of high-tech enterprises, and continue to learn more for the building of biosafety city.

 

新闻动态